Liver Diseases Clinical Trial
Official title:
Preoperative Evaluation of the Remaining Part of the Liver for Liver Resection
- Review the outcomes of the current treatments modalities.
- Give an effective treatment .
- Improve the outcome of these patients and decease rate of recurrence and complications.
- An adequate future liver remnant (FLR) reduces the risk of postoperative liver failure
after major hepatectomy.
- incurs a risk of postoperative liver dysfunction and infection and there is a lack of
objective evidence relating residual liver volume to these complications
A liver resection is the surgical removal of all or a portion of the liver. It is also
referred to as a hepatectomy, full or partial. A complete liver resection is performed in the
setting of a transplant a diseased liver is removed from a deceased donor (cadaver). A living
donor may also provide a piece of liver tissue which is procured through a partial
hepatectomy, The procedure may be performed through a traditional open procedure or using
minimally invasive techniques.
When is Liver Resection Performed Most hepatectomies are performed for the treatment of
hepatic neoplasms, both benign or malignant. Benign neoplasms include hepatocellular adenoma,
hepatic hemangioma and focal nodular hyperplasia.The most common malignant neoplasms
(cancers) of the liver are metastases; those arising from colorectal cancer are among the
most common, and the most amenable to surgical resection. The most common primary malignant
tumour of the liver is the hepatocellular carcinoma. Hepatectomy may also be the procedure of
choice to treat intrahepatic gallstones or parasitic cysts of the liver.
Liver surgery is safe when performed by experienced surgeons with appropriate technological
and institutional support. As with most major surgical procedures, there is a marked tendency
towards optimal results at the hands of surgeons with high caseloads in selected centres
(typically cancer academic medical centers and transplantation centers).
Partial hepatectomy is surgery to remove part of the liver. Only people with good liver
function who are healthy enough for surgery and who have a single tumor that has not grown
into blood vessels can have this operation.
Imaging tests, such as CT or MRI with angiography are done first to see if the cancer can be
removed completely. Still, sometimes during surgery the cancer is found to be too large or
has spread too far to be removed, and the surgery that has been planned cannot be done.
Can a portion of the remaining normal liver grow back? When a portion of a normal liver is
removed, the remaining liver can grow back (regenerate) to the original size within several
weeks. A cirrhotic liver, however, cannot grow back. Therefore, before resection is performed
for HCC, the non-tumor portion of the liver should be biopsied to determine whether there is
associated cirrhosis.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05255042 -
Tissue Models for Liver Disease
|
||
Completed |
NCT04473482 -
Michigan Alcohol Improvement Network- Alcohol Reduction and Treatment Trial
|
N/A | |
Not yet recruiting |
NCT05120557 -
Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH
|
N/A | |
Completed |
NCT02917408 -
Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital
|
||
Recruiting |
NCT03773887 -
Comparison of Inflammatory Profiles and Regenerative Potential in Alcoholic Liver Disease
|
N/A | |
Recruiting |
NCT00345930 -
DILIN - Prospective Study
|
||
Completed |
NCT00148031 -
Improving Hepatitis C Treatment in Injection Drug Users
|
Phase 4 | |
Terminated |
NCT00031135 -
Total Parenteral Nutrition-Associated Liver Disease
|
Phase 2 | |
Completed |
NCT00005305 -
Hepatitis Delta Infections in Hemophiliacs
|
N/A | |
Completed |
NCT00005304 -
Delta Hepatitis and Liver Disease in Hemophiliacs
|
||
Completed |
NCT00222664 -
Qidong Hepatitis B Intervention Study
|
Phase 4 | |
Recruiting |
NCT06195917 -
Robotic-assisted Percutaneous Transhepatic Puncture
|
N/A | |
Recruiting |
NCT04551742 -
Social & Contextual Impact on Children Undergoing Liver Transplantation
|
||
Completed |
NCT04782050 -
Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology Consultation
|
N/A | |
Completed |
NCT03614039 -
Effect of Probiotic and Smectite Gel on NAFLD
|
N/A | |
Recruiting |
NCT04518852 -
TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC
|
Phase 2 | |
Recruiting |
NCT05499585 -
Treating Pediatric NAFLD With Nutrition
|
N/A | |
Terminated |
NCT03396705 -
Liver Regeneration
|
||
Completed |
NCT04341012 -
Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases
|
||
Recruiting |
NCT05733832 -
A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease
|
N/A |